Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA.
Cancer Res. 2010 Jan 1;70(1):388-97. doi: 10.1158/0008-5472.CAN-09-2153.
Questions persist about the nature and number of cells with tumor-propagating capability in different types of cancer, including melanoma. In part, this is because identification and characterization of purified tumorigenic subsets of cancer cells has not been achieved to date. Here, we report tumor formation after injection of single purified melanoma cells derived from three novel mouse models. Tumor formation occurred after every injection of individual CD34+p75- melanoma cells, with intermediate rates using CD34-p75- cells, and rarely with CD34-p75+ cells. These findings suggest that tumorigenic melanoma cells may be more common than previously thought and establish that multiple distinct populations of melanoma-propagating cells (MPC) can exist within a single tumor. Interestingly, individual CD34-p75- MPCs could regenerate cellular heterogeneity after tumor formation in mice or multiple passages in vitro, whereas CD34+p75- MPCs underwent self-renewal only, showing that reestablishment of tumor heterogeneity is not always a characteristic of individual cells capable of forming tumors. Functionally, single purified MPCs were more resistant to chemotherapy than non-MPCs. We anticipate that purification of these MPCs may allow a more comprehensive evaluation of the molecular features that define tumor-forming capability and chemotherapeutic resistance in melanoma.
关于具有肿瘤增殖能力的细胞的性质和数量在不同类型的癌症中仍然存在疑问,包括黑色素瘤。部分原因是,迄今为止尚未实现对纯化的肿瘤发生亚群的癌症细胞的鉴定和特征描述。在这里,我们报告了从三个新型小鼠模型中分离的单个纯化黑色素瘤细胞注射后的肿瘤形成情况。每个注射单个 CD34+p75-黑色素瘤细胞都能形成肿瘤,而 CD34-p75-细胞的发生率中等,而 CD34-p75+细胞很少形成肿瘤。这些发现表明,肿瘤发生的黑色素瘤细胞可能比以前认为的更为常见,并证实了在单个肿瘤中可能存在多个不同的黑色素瘤增殖细胞(MPC)群体。有趣的是,单个 CD34-p75- MPC 在小鼠肿瘤形成或体外多次传代后可以再生细胞异质性,而 CD34+p75- MPC 仅能自我更新,这表明肿瘤异质性的重建并不总是能够形成肿瘤的单个细胞的特征。在功能上,单个纯化的 MPC 比非 MPC 对化疗更具抵抗力。我们预计,这些 MPC 的纯化可能允许更全面地评估定义黑色素瘤形成能力和化疗耐药性的分子特征。